Latest and Past News
-
CHS strongly supports CBS’ plasma initiative
Montreal, September 7, 2022 – “The Canadian Hemophilia Society (CHS) strongly supports Canadian Blood Services’ plans to work with a leading company in the plasma...
-
In Memoriam – Janet Conners
The CHS is deeply saddened to hear of the passing on August 20, 2022, of a former Nova Scotia Chapter President, Janet Conners, at age...
-
The CHS attends Newfoundland and Labrador Family Camp 2022
by Wendy Quinn, President of the Canadian Hemophilia Society This summer I had the great privilege of finally attending the infamous Camp Blast – the...
-
No change to factor IX product mix in Quebec
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022...
-
2022 James Kreppner Memorial Scholarship and Bursary Program recipients
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who...
-
The FactorFirst card has been revised
The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...
-
Important CHS survey on gene therapy
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...
-
Blood donation: dispelling a myth
Eligibility for blood donation in Canada is constantly evolving. For many years, the sexual partners of people with bleeding disorders were deferred from blood donation....
-
Hearing the patient voice on therapy choice: FVIII or non-FVIII
by the Canadian Association of Nurses in Hemophilia Care – Ontario Region* and Sarah Crymble, Ontario Hemophilia Provincial Coordinator Treatment for patients with hemophilia A...
-
Memorial art – helping to prevent future calamity … helping to heal
by Rick Waines, British Columbia In 1983 I was 17 and attended my first WFH meeting in Stockholm, Sweden, and at the opening plenary Dr....
-
Return of Octostim spray delayed until late 2024
In a letter to the European Haemophilia Consortium dated May 31, 2022, Ferring Pharmaceuticals informed the bleeding disorder community that Octostim (desmopressin) Nasal Spray 1.5...
-
CHS Board of Directors
Meet the CHS Board of Directors! From left to right: First row: Cyril Boulila, Wendy Quinn, Leanne Owen. Back row: Dr. Lawrence Jardine, Derek Klatt,...
-
WFH 2022 Congress experience from a social worker’s perspective
by Karen Mantyka, Social worker, Saskatchewan Bleeding Disorders Program This year marked the 35th WFH World Congress, which was held in Montreal, Canada where thousands...
-
The CHS appoints new CEO
CLICK HERE to read the official announcement from CHS President, Wendy Quinn.